Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Oct 31, 2018

BUY
$29.37 - $49.48 $968,064 - $1.63 Million
32,961 Added 11.3%
324,650 $9.54 Million
Q2 2018

Jul 31, 2018

BUY
$42.06 - $62.4 $5.65 Million - $8.38 Million
134,274 Added 85.3%
291,689 $13.3 Million
Q1 2018

Apr 26, 2018

SELL
$50.12 - $67.72 $2.09 Million - $2.83 Million
-41,723 Reduced 20.95%
157,415 $8.31 Million
Q4 2017

Feb 06, 2018

SELL
$57.69 - $84.58 $4.25 Million - $6.23 Million
-73,675 Reduced 27.01%
199,138 $13.5 Million
Q3 2017

Oct 30, 2017

BUY
$67.17 - $84.81 $18.3 Million - $23.1 Million
272,813
272,813 $22.5 Million

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0

About Clovis Oncology, Inc.


  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Emerald Mutual Fund Advisers Trust Portfolio

Follow Emerald Mutual Fund Advisers Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.